We build world-changing businesses.

Scientific breakthroughs can solve our biggest challenges – from infectious diseases and cancer to cyber security, shortages of natural resources, and climate change. But only when they make it out of the lab.

We are Oxford Science Enterprises, an independent, billion-pound investment company created in 2015 to found, fund and build transformational businesses via our unique partnership with the University of Oxford, the world’s #1 research university.

This partnership enables us to work with the brightest academic minds tackling the world’s toughest challenges and guarantees us unrivalled access to their scientific research. In collaboration with our global network of entrepreneurs and advisors, we shape and nurture these complex ideas into successful businesses, while targeting attractive returns for shareholders.

Actively focused on three key high-growth, high-impact sectors – Life Sciences, Health Tech and Deep Tech – we adopt a flexible, long-term investment approach recognising the path from ground-breaking research to global markets takes time and resilience.

A key player in Oxford’s entrepreneurial ecosystem, we are highly motivated to foster an environment that catalyses pioneering research and steers it to commercial success. We are committed to doing this in an inclusive and sustainable way.

Cover_v33

Updates

Today @PepGenTx released its second quarter 2022 financial results and a corporate update, including many noteworthy highlights.

Read the full release ⬇

https://bit.ly/3dnAsw8

We released 2Q22 financial results and corporate update:
(1) $32.1m royalty payment from commercial sales of Vaxzevria®
(2) Announced positive data from VTP-300 trial
(3) Enrolled 60th patient in VTP-200 trial
(4) Notable upcoming milestones

See: https://bit.ly/3BQ9CH5

Delighted to announce that our portfolio company
@Miro_Bio is to be acquired by @GileadSciences for approximately $405 million.

Read our full press release to learn more ⬇

https://bit.ly/3zzzJ2i

Stay up to date

Get the latest on cutting edge developments from our enterprises straight to your inbox